Hedge Fund Database
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
The curated database of hedge funds that publish investor letters. Research by geography, strategy, and schools of thought.
| # | Fund | Strategy | Style | Geography | AUM | Latest Letter |
|---|---|---|---|---|---|---|
As of May 1, 2025
Rogue Funds declined 12.4% in Q1 2025 but manager Jacob Rowe expresses increased confidence in the portfolio heading into year three. The fund maintains a concentrated approach focused on catalyst-driven small-cap investments across uranium, biotechnology, data centers, and healthcare technology. Key holdings include ASP Isotopes, which has begun full production and expects significant revenue catalysts through Q4, and Global Atomic, benefiting from improved geopolitical conditions in Niger. The fund also holds Achieve Life Sciences, despite recent frustrations, with potential 5x-8x upside following upcoming clinical milestones. New positions include Biotricity, a healthcare technology company transitioning to an AI-focused SAAS model with pilot studies launching imminently. The portfolio has become more concentrated while removing all leverage due to expected macro volatility. Multiple catalysts are anticipated through August-September, with the manager expecting this could be the fund's best year despite continued high volatility from the concentrated positioning strategy.
Concentrated small-cap strategy focused on catalyst-driven investments in uranium, biotechnology, data centers, and healthcare technology with multiple near-term value inflection points expected over the next 6-9 months.
Manager expects third year of the Fund to possibly be the best year thus far with much more confidence in portfolio direction. Multiple catalysts expected through August/September timeframe with continuous stream of events through Q4. Volatility will continue but catalyst-driven strategy expected to separate returns from market despite being mainly long-only fund.
High Conviction Bullish
Market Conviction
Growth Outlook
Risk Appetite
Capital Deployment
Forward Guidance
Language Signal
Perceived Risk
Opportunity Density
Time Horizon
Top Conviction Themes
Key Catalysts
Every insight in this database connects to the original source. Read the actual thesis, see the actual concerns, and make your own call.
Buyside Digest has no business relationship, partnership, agency, sponsorship, endorsement, or affiliation with Rogue Funds, LLC or any other manager whose content appears on the Service, except where expressly stated. We do not receive Manager Content directly from managers in most cases; content is collected from publicly available sources. Managers have not necessarily reviewed, approved, authorized, or endorsed our display of their content, our editorial commentary, our metadata extraction, or our classifications. Use of a manager’s name is for accurate attribution and identification purposes only, under principles of nominative fair use.
Buyside Digest does not independently verify the regulatory status, registrations, licensing, qualifications, credentials, or professional standing of managers whose content appears on the Service. We do not represent that managers are properly registered with applicable regulatory bodies, that their content complies with applicable securities laws, or that their performance representations are accurate. Inclusion of a manager in our database is based on the publicly available nature of their content, not on our verification of their regulatory status or content compliance. Users are responsible for conducting their own due diligence on any manager.
Performance data, returns, assets under management (“AUM”), and similar figures displayed on this page are sourced from publicly available manager communications (including investor letters), public filings, or other third-party sources. Buyside Digest does not independently verify performance figures, calculate returns, or audit manager-reported data. Such figures: May be selectively reported by the manager; May use non-standard calculation methodologies; May not reflect fees, expenses, taxes, or other costs; May be inconsistent across reporting periods; May be outdated. Past performance is not indicative of future results. Performance figures should not be relied upon for investment decisions without independent verification. Users should request audited performance data directly from the manager and conduct their own due diligence.